IPH Innate Pharma IPH’s tracks ESMO 2018: Phase II trial of monalizumab and cetuximab by IPH published on 2018-10-22T16:27:56Z Innate_Pharma_19022015.WAV by IPH published on 2015-02-23T16:08:17Z